RP-1208

N/A

Report date: 2025/05/26 16:48:19
NME

Base Information

Drug NameRP-1208
Drug Alias NameRP-1208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine reuptake inhibitorsSerotonin reuptake inhibitorsNorepinephrine uptake inhibitors
TargetsDopamine transporterSerotonin transporterNorepinephrine transporter
Therapy Area/IndicationsDepressive DisorderObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReviva Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesReviva Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDepressive DisorderObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A